VNO
65
2
AMAT
60
7
VZ
55
-2
CI
40
-9
MDT
60
4
APD
44
2
LH
53
-9
NTRS
77
10
CCL
81
11
SE
88
6
HD
60
6
STX
78
8
SLB
42
4
EFX
79
5
JCI
60
3
ZION
75
10
AXP
78
7
APH
83
3
BIIB
45
6
WMT
70
2
VNO
65
2
AMAT
60
7
VZ
55
-2
CI
40
-9
MDT
60
4
APD
44
2
LH
53
-9
NTRS
77
10
CCL
81
11
SE
88
6
HD
60
6
STX
78
8
SLB
42
4
EFX
79
5
JCI
60
3
ZION
75
10
AXP
78
7
APH
83
3
BIIB
45
6
WMT
70
2
Financhill
Back

EyePoint Pharmaceuticals Stock Predictions

Former Zillow execs target $1.3T market

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
35

EYPT
EyePoint Pharmaceuticals

Last Price:
$5.92
Seasonality Move:
2.04%

7 Day Trial

ALL ACCESS PASS

$ 7

Missed investing in Uber? Don't Miss Mode.

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

EyePoint Pharmaceuticals Stock Forecast

  • Over the next 52 weeks, EyePoint Pharmaceuticals has on average historically fallen by 3.1% based on the past 20 years of stock performance.
  • EyePoint Pharmaceuticals has fallen lower in 11 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 55%
  • Is EyePoint Pharmaceuticals Stock Undervalued?
    The current EyePoint Pharmaceuticals [EYPT] share price is $5.85. The Score for EYPT is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • EYPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will EyePoint Pharmaceuticals Stock Go Up Next Year?

  • Over the next 52 weeks, EyePoint Pharmaceuticals has on average historically fallen by 3.1% based on the past 20 years of stock performance.

EyePoint Pharmaceuticals Stock Rating

Sell
35
EyePoint Pharmaceuticals (EYPT) is a Sell

Is EyePoint Pharmaceuticals overpriced?

  • EyePoint Pharmaceuticals has fallen lower in 11 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 55%

EyePoint Pharmaceuticals Stock Price History

Is EYPT stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EYPT is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
eyepointpharma.com

52-Week Data

52-Week High:
13.99
52-Week Low:
3.91

Prediction Charts

Market Cap:
402.5M
Price in USD:
5.85
Volume:
529.6K
Beta:
1.87

Technical Analysis

SMA50:
6.09
SMA100:
6.71
SMA200:
7.96
52-Wk Change:
-51.61%

Stock Predictions

  • Is EyePoint Pharmaceuticals stock public?
    Yes, EyePoint Pharmaceuticals is a publicly traded company.
  • What is the EyePoint Pharmaceuticals stock quote today?
    The EyePoint Pharmaceuticals stock price is 5.85 USD today.
  • How to buy EyePoint Pharmaceuticals stock online?
    You can buy EyePoint Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-23 6.70 6.71 7.00 6.55
Apr-24 6.69 6.54 6.71 6.45
Apr-25 6.45 6.37 6.60 6.06
Apr-28 6.38 6.78 6.91 6.38
Apr-29 6.72 6.64 6.86 6.48
Apr-30 6.54 6.82 6.90 6.49
May-1 6.81 7.13 7.17 6.74
May-2 7.19 7.30 7.45 7.06
May-5 7.18 6.86 7.25 6.79
May-6 6.82 6.25 6.86 6.20
May-7 6.38 6.09 6.79 5.75
May-8 6.09 6.10 6.31 5.91
May-9 6.10 5.81 6.23 5.75
May-12 6.08 5.85 6.29 5.82

EyePoint Pharmaceuticals Earnings

EyePoint Pharmaceuticals Earnings Report: Per Share EyePoint Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.

EyePoint Pharmaceuticals Forecast Revenue Growth

EyePoint Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for EyePoint Pharmaceuticals and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.14 per share, an increase this year of $0.11 per share, and a decrease next year of $0.90 per share.

* EyePoint Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.